Article Information
History
- March 31, 2023.
Article Versions
- You are currently viewing Version 1 of this article (March 31, 2023 - 15:12).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Benjamin Charvet1,
- Alexandre Lucas2,
- Justine Pierquin1,
- Joanna Brunel1,
- Steven Fried3,
- Corinne Bernis3,
- Zachary S. Orban3,
- Millenia Jimenez3,
- Barbara A. Hanson3,
- Lavanya Visvabharathy3,
- Igor J. Koralnik3 and
- Hervé Perron, PhD1,*
- 1Geneuro-Innovation, Bioparc Laennec, 69008, Lyon, France
- 2We-Met platform, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), plateau We-Met, Inserm UMR1297 and Université Paul Sabatier, Toulouse, France
- 3Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- ↵*Correspondence:
hperron{at}geneuro.com; Hervé Perron, Geneuro-Innovation, Bioparc Laënnec, 60A Avenue Rockefeller, 69008, Lyon, France. tel : +33 437 902 997